Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial. (2018)
Attributed to:
Dissecting the steroid metabolome in the pathogenesis and treatment of metabolic liver disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12902-018-0315-6
PubMed Identifier: 30477455
Publication URI: http://europepmc.org/abstract/MED/30477455
Type: Journal Article/Review
Volume: 18
Parent Publication: BMC endocrine disorders
Issue: 1
ISSN: 1472-6823